Selenium in the Therapy of Neurological Diseases. Where is it Going?
Journal:
Current Neuropharmacology
Volume:
14
Page:
282-299
Author(s):
Agnieszka Dominiak, Anna Wilkaniec*, Piotr Wroczyński and Agata Adamczyk
Recent Evidence of the Regulatory Role of PPARs in Neural Stem Cells and Their Underlying Mechanisms for Neuroprotective Effects
Journal:
Current Stem Cell Research & Therapy
Volume:
11
Page:
188-196
Author(s):
Jing Wang, Yun Shen, Yiming Zhang, Rui Zhang, Xiaoshan Tang, Li Fang and Yuanzhi Xu
Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Journal:
Current Enzyme Inhibition
Volume:
12
Page:
81-107
Author(s):
Lakshmikirupa Sundaresan, Suvendu Giri and Suvro Chatterjee
Targeting the Autophagy/Lysosomal Degradation Pathway in Parkinson´s Disease
Journal:
Current Neuropharmacology
Volume:
14
Page:
238-249
Author(s):
Pilar Rivero-Ríos, Jesús Madero-Pérez,, Belén Fernández and Sabine Hilfiker
Complex and Differential Glial Responses in Alzheimer´s Disease and Ageing
Journal:
Current Alzheimer Research
Volume:
13
Page:
343-358
Author(s):
José J. Rodríguez, Arthur M. Butt, Emanuela Gardenal, Vladimir Parpura and Alexei Verkhratsky
Decreased Regenerative Capacity of Oligodendrocyte Progenitor Cells (NG2-Glia) in the Ageing Brain: A Vicious Cycle of Synaptic Dysfunction, Myelin Loss and Neuronal Disruption?
Journal:
Current Alzheimer Research
Volume:
13
Page:
413-418
Author(s):
Andrea Rivera, Ilaria Vanzuli, José Julio Rodríguez Arellano and Arthur Butt
Metabolic Control of Glia-Mediated Neuroinflammation
Journal:
Current Alzheimer Research
Volume:
13
Page:
387-402
Author(s):
Mithilesh Kumar Jha, Dong Ho Park, Hyun Kook, In-Kyu Lee, Won-Ha Lee and Kyoungho Suk
Editorial (Thematic Issue: Neurodegeneration, Oxidative Stress, Metabolic Syndrome, Drug Design and Development: Clinical Implications)
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
126-126
Author(s):
Ramon Cacabelos, V. Prakash Reddy and Gjumrakch Aliev
The Co-Metabolism within the Gut-Brain Metabolic Interaction: Potential Targets for Drug Treatment and Design
Journal:
CNS & Neurological Disorders - Drug Targets
Volume:
15
Page:
127-134
Author(s):
Mark Obrenovich, Rudolf Flückiger, Lorraine Sykes and Curtis Donskey
Tryptophan Catabolites and Their Impact on Multiple Sclerosis Progression
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
1049-1059
Author(s):
Jens O. Watzlawik, Bharath Wootla and Moses Rodriguez